Skip to main content
. 2022 Jan 15;26(5):2659–2678. doi: 10.1007/s11030-021-10359-4

Fig. 2.

Fig. 2

Protein–protein interactions between the ST2 receptor and its ligand IL-33. A X-ray co-crystallized structure of ST2/IL-33 complex (PDB ID: 4KC3) with magnified binding site 1. B Isolated key residues on the binding interface of the ST2 receptor (in magenta) and IL-33 (in green)